Michael Harrison Storandt

11PUBLICATIONS
17CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Cancer diagnosisCancer geneticsPredictive and prognostic markersEpidemiological modelling
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (11)

|Jul 28, 2026
Atezolizumab Plus Bevacizumab Versus Durvalumab Plus Tremelimumab for Advanced Hepatocellular Carcinoma: A Propensity-Score-Matched Analysis.

|Feb 19, 2026
Deficient mismatch repair/microsatellite instability-high colorectal cancer: current treatment paradigms, limitations and future perspectives.

Michael H Storandt, Frank A Sinicrope

|Jan 28, 2026
Glucagon-like Peptide-1 Receptor Agonist Use and Pancreatic Cancer Risk in Patients with Chronic Pancreatitis.

Sarina Ailawadi, Jennifer E Murphy, Michael H Storandt

|Mar 13, 2025
Genomic Landscapes of Early-Onset Versus Average-Onset Colorectal Cancer Populations.

Michael H Storandt, Qian Shi, Cathy Eng

|Jul 13, 2024
Circulating Tumor DNA Predicts Early Recurrence Following Locoregional Therapy for Oligometastatic Colorectal Cancer.

Conor D J O'Donnell, Nikolas Naleid, Teerada Siripoon

|May 25, 2024
Frequency of Common and Uncommon BRAF Alterations among Colorectal and Non-Colorectal Gastrointestinal Malignancies.

Amit Mahipal, Michael H Storandt, Emily A Teslow

Pageof 2

Frequent Collaborators

7 joint publications

Zhaohui Jin

6 joint publications

Amit Mahipal

2 joint publications

Sri Harsha Tella

2 joint publications

Emily A Teslow